마이크로플루이딕스 시장 : 재료, 컴포넌트, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Microfluidics Market was valued at USD 25.53 billion in 2023, expected to reach USD 31.84 billion in 2024, and is projected to grow at a CAGR of 25.37%, to USD 124.31 billion by 2030.

Microfluidics, a multidisciplinary field intersecting engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology, involves the manipulation of small volumes of fluids in micro-channels. Its scope extends across various applications such as drug development, clinical diagnostics, and environmental monitoring, serving industries including healthcare, pharmaceuticals, and environmental science. The necessity of microfluidics arises from its ability to conduct high-efficiency, cost-effective analyses with reduced sample and reagent volumes, thus providing rapid results. Its applications are broad but are particularly pivotal in point-of-care testing, pathogen detection, and personalized medicine, driven by the growing demand for decentralizing healthcare services and rapid diagnostics.

Key growth factors influencing the microfluidics market include advancements in miniaturization technologies, increased funding for research and development, and the rising prevalence of chronic diseases necessitating innovative diagnostic solutions. The integration of microfluidics with AI and machine learning presents substantial opportunities, especially in developing smart, autonomous lab-on-a-chip devices. To capitalize on these opportunities, stakeholders should focus on interdisciplinary collaborations and expanding capabilities in automation and digitization.

However, challenges such as the high cost of devices, complex manufacturing processes, and stringent regulatory requirements can impede market growth. Overcoming these limitations will require strategic investments in scalable manufacturing technologies and streamlined regulatory pathways. Areas ripe for innovation include developing low-cost, user-friendly microfluidics systems for home healthcare settings, and exploring new materials like paper-based microfluidics for sustainability and cost reduction.

The microfluidics market, characterized by rapid technological advancements and a high degree of competition, offers substantial growth prospects. Companies should target strategic mergers and acquisitions to enhance their product portfolios and geographical reach. Insights indicate that as the demand for portable and rapid diagnostic solutions increases, emphasizing the development of integrated systems with enhanced sensitivity and specificity can position businesses for leadership in this evolving market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Microfluidics Market

The Microfluidics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
  • Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
  • Potential Applications of Drug Delivery using Microfluidics
• Market Restraints
  • Complicated and Time-Consuming Regulatory Approval Process
• Market Opportunities
  • Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
  • Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
• Market Challenges
  • Integration of Microfluidics with Existing Workflows

Porter's Five Forces: A Strategic Tool for Navigating the Microfluidics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Microfluidics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Microfluidics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Microfluidics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Microfluidics Market

A detailed market share analysis in the Microfluidics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Microfluidics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Microfluidics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ascent Bio-Nano Technologies, Inc., Camozzi Automation S.p.A., Dolomite Microfluidics, IMT Masks and Divisions AG, PerkinElmer Inc., Thermo Fisher Scientific, Inc., Mission Bio, Inc., Idex Corporation, NanoCellect Biomedical., Abaxis, Inc., Quidel Corporation, Koninklijke Philips N.V., Parker-Hannifin Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Agilent Technologies, Inc., Danaher Corporation, Biosurfit SA, SMC Corporation, Micropoint Bioscience, Inc., Fluigent S.A., Elvesys Group, Achira Labs Pvt. Ltd., Sphere Fluidics Limited, OPKO Health, Inc., Cellix Limited, AbCellera Biologics Inc., and Fluidigm Corporation by Standard BioTools Inc..

Market Segmentation & Coverage

This research report categorizes the Microfluidics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Material, market is studied across Glass-based, Polymer-based, and Silicon-based.
• Based on Component, market is studied across Micro Needle, Micro Pump, and Microfluidic Chip.
• Based on Application, market is studied across In-Vitro Diagnostics, Pharmaceutical & Life Science Research, and Therapeutics. The In-Vitro Diagnostics is further studied across Clinical Diagnostics, Point-Of-Care Testing, and Veterinary Diagnostics. The Pharmaceutical & Life Science Research is further studied across Lab Analytics, Microdispensing, and Microreaction. The Lab Analytics is further studied across Capillary Electrophoresis, Cell-based Assays, Genomic analysis, and Proteomic Analysis. The Therapeutics is further studied across Drug Delivery and Wearable Devices.
• Based on End User, market is studied across Academic & Research Institutes, Hospitals & Diagnostic Centers, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
    • 5.1.1.2. Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
    • 5.1.1.3. Potential Applications of Drug Delivery using Microfluidics
  • 5.1.2. Restraints
    • 5.1.2.1. Complicated and Time-Consuming Regulatory Approval Process
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
    • 5.1.3.2. Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
  • 5.1.4. Challenges
    • 5.1.4.1. Integration of Microfluidics with Existing Workflows
• 5.2. Market Segmentation Analysis
  • 5.2.1. Material: Increasing use of glass and silicon-based materials for microfluidic devices
  • 5.2.2. Component: Adoption of microneedles and pumps for minimal risk of infection
  • 5.2.3. Application: Significant application of microfluidic devices in IVD and therapeutics
  • 5.2.4. End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Microfluidics Market, by Material

• 6.1. Introduction
• 6.2. Glass-based
• 6.3. Polymer-based
• 6.4. Silicon-based

7. Microfluidics Market, by Component

• 7.1. Introduction
• 7.2. Micro Needle
• 7.3. Micro Pump
• 7.4. Microfluidic Chip

8. Microfluidics Market, by Application

• 8.1. Introduction
• 8.2. In-Vitro Diagnostics
  • 8.2.1. Clinical Diagnostics
  • 8.2.2. Point-Of-Care Testing
  • 8.2.3. Veterinary Diagnostics
• 8.3. Pharmaceutical & Life Science Research
  • 8.3.1. Lab Analytics
    • 8.3.1.1. Capillary Electrophoresis
    • 8.3.1.2. Cell-based Assays
    • 8.3.1.3. Genomic analysis
    • 8.3.1.4. Proteomic Analysis
  • 8.3.2. Microdispensing
  • 8.3.3. Microreaction
• 8.4. Therapeutics
  • 8.4.1. Drug Delivery
  • 8.4.2. Wearable Devices

9. Microfluidics Market, by End User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Hospitals & Diagnostic Centers
• 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Microfluidics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Microfluidics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Microfluidics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform
  • 13.3.2. Bio-Techne to acquire Swiss spatial biology firm Lunaphore
  • 13.3.3. CellFE Announces Launch of Novel Microfluidic Cellular Engineering Platform at ASGCT 2023 Annual Meeting

Companies Mentioned

• 1. Abbott Laboratories
• 2. Ascent Bio-Nano Technologies, Inc.
• 3. Camozzi Automation S.p.A.
• 4. Dolomite Microfluidics
• 5. IMT Masks and Divisions AG
• 6. PerkinElmer Inc.
• 7. Thermo Fisher Scientific, Inc.
• 8. Mission Bio, Inc.
• 9. Idex Corporation
• 10. NanoCellect Biomedical.
• 11. Abaxis, Inc.
• 12. Quidel Corporation
• 13. Koninklijke Philips N.V.
• 14. Parker-Hannifin Corporation
• 15. Illumina, Inc.
• 16. Bio-Rad Laboratories, Inc.
• 17. BioFluidica
• 18. Agilent Technologies, Inc.
• 19. Danaher Corporation
• 20. Biosurfit SA
• 21. SMC Corporation
• 22. Micropoint Bioscience, Inc.
• 23. Fluigent S.A.
• 24. Elvesys Group
• 25. Achira Labs Pvt. Ltd.
• 26. Sphere Fluidics Limited
• 27. OPKO Health, Inc.
• 28. Cellix Limited
• 29. AbCellera Biologics Inc.
• 30. Fluidigm Corporation by Standard BioTools Inc.